Details for New Drug Application (NDA): 085490
✉ Email this page to a colleague
NDA 085490 describes TESTOSTERONE PROPIONATE, which is a drug marketed by Bel Mar, Elkins Sinn, Lilly, and Watson Labs, and is included in eight NDAs. Additional details are available on the TESTOSTERONE PROPIONATE profile page.
The generic ingredient in TESTOSTERONE PROPIONATE is testosterone propionate. There are sixty-nine drug master file entries for this compound. Additional details are available on the testosterone propionate profile page.
The generic ingredient in TESTOSTERONE PROPIONATE is testosterone propionate. There are sixty-nine drug master file entries for this compound. Additional details are available on the testosterone propionate profile page.
Summary for 085490
| Tradename: | TESTOSTERONE PROPIONATE |
| Applicant: | Watson Labs |
| Ingredient: | testosterone propionate |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 25MG/ML | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 50MG/ML | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
